Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase
about
Angiopoietin-like 4 based therapeutics for proteinuria and kidney diseaseAngiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in miceAngptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophagesCommon variants at 30 loci contribute to polygenic dyslipidemiaExpression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors.Hypoxia-activated genes from early placenta are elevated in preeclampsia, but not in Intra-Uterine Growth Retardation.The ANGPTL3-4-8 model, a molecular mechanism for triglyceride traffickingProbiotics and Prebiotics: Present Status and Future Perspectives on Metabolic DisordersNew insights into human minimal change disease: lessons from animal modelsAngiopoietin Like Protein 2 (ANGPTL2) Promotes Adipose Tissue Macrophage and T lymphocyte Accumulation and Leads to Insulin ResistanceAngiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubesThe angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanismsThe gut microbiota as an environmental factor that regulates fat storageHonor thy symbiontsFatty acid-inducible ANGPTL4 governs lipid metabolic response to exerciseLipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout miceAngiopoietin-like protein 4: health effects, modulating agents and structure-function relationshipsAngiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formationANGPTL4 is produced by entero-endocrine cells in the human intestinal tractMice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasisOligomerization and regulated proteolytic processing of angiopoietin-like protein 4Differential regulation and properties of angiopoietin-like proteins 3 and 4The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormoneComparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytesShort-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γGnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiotaNovel LMF1 nonsense mutation in a patient with severe hypertriglyceridemiaDecreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4)Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sampleEffects of High-Fat Feeding on Skeletal Muscle Gene Expression in Diabetic Goto-Kakizaki RatsInhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart.Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response.Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.Skin healing and scale regeneration in fed and unfed sea bream, Sparus auratus.The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.GPIHBP1, an endothelial cell transporter for lipoprotein lipase.Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo.Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight.Jejunal wall triglyceride concentration of morbidly obese persons is lower in those with type 2 diabetes mellitus.Adaptive ridge regression for rare variant detection.
P2860
Q21129275-6CEE9FF2-9CE7-46B8-9574-D21A773A785FQ24523697-033F124E-E697-4221-ACDE-5811C2E6DBAFQ24594623-FFC262D6-9D91-4ACB-9BED-00AF3441402EQ24598765-BF2E2538-8DD5-4C78-9CA5-FE528694C307Q24803501-A2CF7D25-1929-46F8-88EE-0976D8C1C96DQ24816630-B66337EA-FEB3-4CBB-9F3E-86B03E113EC1Q26751057-2B2E19A0-F4C0-454D-8C89-3F29DA708A54Q26752979-AA55226B-DB04-4118-8CD8-C263A0D2E6BBQ26853392-8C71FE9C-D2B8-4134-AAE8-6538D277CFAFQ27303704-08EA37AE-B55E-40F8-ACC9-0BF7CF34734BQ27316586-AEF27F5C-68EC-4469-AE93-DF6BAA84708DQ28118447-641D73A4-57E5-48CA-90EE-1F4EA59A042BQ28131676-DD8BE8BC-9EAA-4BD4-9E39-6F5477CD6080Q28202174-539B8327-23D1-43CE-A25B-629A68BBCFF2Q28235151-A3FF5224-A4D5-42AE-936B-5447B2904796Q28235182-9B975747-1D91-45BE-9162-52E490604144Q28263229-927EB14B-2FD4-461C-8DF8-AB3AF226D46FQ28296885-8760E16C-C780-4EBB-B3E3-F14869CC87E9Q28300566-72A95CE7-BCD7-448A-BB9D-497334ED1BCFQ28504875-8B636407-1B81-41BC-8A40-B392434BA936Q28565894-4094AECA-DB82-46E6-81B6-E14B852FD8A2Q28579076-A5E49CB7-408E-45BB-93F9-BECF7E6780BAQ28579695-5C8C4C39-CA1F-4ECD-896B-5A05A0ADEAADQ28730590-255028B5-4F75-4CCD-9E72-9B2D83FCEDABQ30538765-BCE063EC-1BB1-4208-82CC-C7802012F3A6Q33201187-A19962A2-6402-456B-B723-BAA792D779ABQ33644452-41E9E3C4-54E7-48BE-A4F1-9606008F1DB2Q33711961-12E02747-8A26-4A13-B710-A1A1904718D2Q33741200-28FA3700-3E11-4F22-B054-C38101A9C582Q33758332-FB08B030-4147-4F5A-95DD-79E2B4C694A7Q33819755-99A106A9-D4E0-424C-AA4D-EF0442D5E898Q33911788-129F7B75-0B8E-4800-82D5-84662B037585Q33968126-53B4F62F-5E79-4390-A290-706670DE298CQ34043851-02CA3EDF-6D56-4487-BD2E-B9CE90501F4DQ34105415-DB7A1641-686F-4CD9-9E50-8BF691830B94Q34208235-AD7E377E-028E-45FF-9DFA-8152E43269CDQ34221134-04E7597A-65A8-4A6D-86B3-050D954C8B29Q34237623-B0811B0E-6563-4D41-94E9-272BAC8D9B74Q34287860-80D362D3-59B3-4A1D-9C10-9F4AD56A581CQ34406366-1E5C96EA-0AA8-42B0-B398-153E9727EFC0
P2860
Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase
description
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im November 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/11/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/11/01)
@nl
наукова стаття, опублікована в листопаді 2002
@uk
مقالة علمية (نشرت في نوفمبر 2002)
@ar
name
Angiopoietin-like protein 4 is ...... nhibitor of lipoprotein lipase
@ast
Angiopoietin-like protein 4 is ...... nhibitor of lipoprotein lipase
@en
Angiopoietin-like protein 4 is ...... nhibitor of lipoprotein lipase
@nl
type
label
Angiopoietin-like protein 4 is ...... nhibitor of lipoprotein lipase
@ast
Angiopoietin-like protein 4 is ...... nhibitor of lipoprotein lipase
@en
Angiopoietin-like protein 4 is ...... nhibitor of lipoprotein lipase
@nl
prefLabel
Angiopoietin-like protein 4 is ...... nhibitor of lipoprotein lipase
@ast
Angiopoietin-like protein 4 is ...... nhibitor of lipoprotein lipase
@en
Angiopoietin-like protein 4 is ...... nhibitor of lipoprotein lipase
@nl
P2093
P3181
P1476
Angiopoietin-like protein 4 is ...... nhibitor of lipoprotein lipase
@en
P2093
Hidehiko Furukawa
Kenichi Yoshida
Mitsuru Ono
Tetsuya Shimizugawa
P304
P3181
P356
10.1194/JLR.C200010-JLR200
P577
2002-11-01T00:00:00Z